D-1326-2015 Class II Terminated
FDA drug recall D-1326-2015 was initiated by Baxter Healthcare Corp. on Jul 2, 2015 and is designated Class II. Reason for recall: Presence of Particulate Matter and Lack of Assurance of Sterility: The firm received a complaint for customer of presence of particulate matter, leaky containers, and missing port protectors. The recall status is terminated (terminated May 26, 2016). Affected quantity: 189,912 containers.
Recall Details
- Product Type
- Drugs
- Report Date
- Aug 19, 2015
- Initiation Date
- Jul 2, 2015
- Termination Date
- May 26, 2016
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 189,912 containers
Product Description
0.9% Sodium Chloride Injection USP, 500 mL in VIAFLEX Plastic Container, Baxter Healthcare Corporation Deerfield, IL 60015, NDC 0338-0049-03.
Reason for Recall
Presence of Particulate Matter and Lack of Assurance of Sterility: The firm received a complaint for customer of presence of particulate matter, leaky containers, and missing port protectors.
Distribution Pattern
TX and TN
Code Information
Lot #: C964601, Exp 4/30/2016
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1326-2015
- openFDA file date
- Oct 27, 2026
- Loaded by RegDataLab
- Oct 29, 2026